Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B8WS
|
|||
| Former ID |
DIB003290
|
|||
| Drug Name |
Zostavax
|
|||
| Synonyms |
Varivax; Varivax II; Varivax ISF; Zoster vaccine live neurological DisorDers; Herpes zostervaccine, Aventis Pasteur MSD; Shingles vaccine, Aventis Pasteur MSD; V-211; Herpes zoster vaccine, Merck & Co; Shingles vaccine, Merck & Co; Oka/Merck varicella vaccine, Merck & Co; Vaccine (varicella zoster), Merck & Co
Click to Show/Hide
|
|||
| Indication | Varicella zoster virus infection [ICD-11: 1E91] | Approved | [1], [2] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT02444936) ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.